|
|
|
Volumn 7, Issue 10, 2004, Pages 904-906
|
|
Inflammation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 (3 FLUORO 4 HYDROXYPHENYL) 7 VINYL 5 BENZOXAZOLOL;
4 (2,3 DIHYDROBENZOFURAN 7 YL) 2 HYDROXY 3,3 DIMETHYL N (4 METHYL 1 OXO 2,3 BENZOXAZIN 6 YL) 2 TRIFLUOROMETHYLBUTANAMIDE;
4 [3 [4 (3,4 DICHLOROBENZYL) 2 MORPHOLINYLMETHYL]UREIDOMETHYL]BENZAMIDE;
AMG 548;
ANTIINFLAMMATORY AGENT;
AZD 6942;
CHEMOKINE RECEPTOR CCR5;
CHEMOKINE RECEPTOR CXCR2;
CYCLOSPORIN A;
ERB 196;
GLUCOCORTICOID RECEPTOR ANTAGONIST;
GW 633647X;
GW 701897X;
GW 782415X;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;
INTERLEUKIN 1;
LFA 703;
LFA 878;
MITOGEN ACTIVATED PROTEIN KINASE P38;
MONOCYTE CHEMOTACTIC PROTEIN 1;
MORPHINE DERIVATIVE;
PRALNACASAN;
PREDNISOLONE;
RECEPTOR BLOCKING AGENT;
SKF 83589;
TIMONACIC DERIVATIVE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VERY LATE ACTIVATION ANTIGEN 4;
VX 765;
AUTACOID;
CHEMOKINE RECEPTOR;
ALLERGIC CONJUNCTIVITIS;
ALLERGIC RHINITIS;
ANTIINFLAMMATORY ACTIVITY;
ASTHMA;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG BIOAVAILABILITY;
DRUG HALF LIFE;
DRUG STRUCTURE;
DRUG TOLERABILITY;
ENTERITIS;
GASTROINTESTINAL TOXICITY;
GRAFT REJECTION;
HIGH THROUGHPUT SCREENING;
HUMAN;
INFLAMMATORY DISEASE;
LIVER TOXICITY;
MAXIMUM TOLERATED DOSE;
NONHUMAN;
PAW EDEMA;
QT PROLONGATION;
RHEUMATOID ARTHRITIS;
SKIN ATROPHY;
STRUCTURE ACTIVITY RELATION;
WEIGHT GAIN;
DRUG ANTAGONISM;
SYNTHESIS;
ANTI-INFLAMMATORY AGENTS;
HUMANS;
INFLAMMATION MEDIATORS;
RECEPTORS, CHEMOKINE;
|
|
EID: 7244238195
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
